Genesis Therapeutics has secured $200 million funding from NVentures, NVIDIA’s venture capital arm. This forms part of an ...
AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...
Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback